Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: mo m. BMJ Open. 2018 Jun 22;8(6):e020286. doi: 10.1136/bmjopen-2017-020286. BMJ Open. 2018. PMID: 29934383 Free PMC article.
Treatment of Primary Varicose Veins in Japan: Japanese Vein Study XVII.
Satokawa H, Yamaki T, Iwata H, Sakata M, Sugano N, Nishibe T, Mo M, Yamada N, Iwai T. Satokawa H, et al. Among authors: mo m. Ann Vasc Dis. 2016;9(3):180-187. doi: 10.3400/avd.oa.16-00064. Epub 2016 Aug 30. Ann Vasc Dis. 2016. PMID: 27738459 Free PMC article.
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: mo m. Circ J. 2020 Oct 23;84(11):1912-1921. doi: 10.1253/circj.CJ-20-0636. Epub 2020 Sep 26. Circ J. 2020. PMID: 32981924 Free article.
CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: mo m. Circ J. 2021;85(3):330. doi: 10.1253/circj.CJ-66-0190. Circ J. 2021. PMID: 33627587 Free article. No abstract available.
Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan.
Yamashita Y, Maruyama Y, Satokawa H, Nishimoto Y, Tsujino I, Sakashita H, Nakata H, Okuno Y, Ogihara Y, Yachi S, Toya N, Shingaki M, Ikeda S, Yamamoto N, Aikawa S, Ikeda N, Hayashi H, Ishiguro S, Iwata E, Umetsu M, Kondo A, Iwai T, Kobayashi T, Mo M, Yamada N; Taskforce of VTE and COVID-19 in Japan Study. Yamashita Y, et al. Among authors: mo m. Circ J. 2021 Nov 25;85(12):2208-2214. doi: 10.1253/circj.CJ-21-0169. Epub 2021 May 20. Circ J. 2021. PMID: 34011824 Free article.
822 results